Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis

Multiple myeloma (MM) is considered to be the second most common blood malignancy and it is characterized by abnormal proliferation and an accumulation of malignant plasma cells in the bone marrow. Although the currently utilized markers in the diagnosis and assessment of MM are showing promising re...

Descripción completa

Detalles Bibliográficos
Autores principales: Soliman, Amro M., Das, Srijit, Teoh, Seong Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305153/
https://www.ncbi.nlm.nih.gov/pubmed/34299097
http://dx.doi.org/10.3390/ijms22147470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305153/
https://www.ncbi.nlm.nih.gov/pubmed/34299097
http://dx.doi.org/10.3390/ijms22147470

Ejemplares similares